Skip to main content
HR 1203 115th Congress House

Safe RESEARCH Act

Official title: To amend the Public Health Service Act to prohibit research with human fetal tissue obtained pursuant to an abortion, and for other purposes.

Introduced: January 30, 2018 See on congress.gov
Health AbortionAdministrative law and regulatory proceduresCell biology and embryologyDepartment of Health and Human Services
More subjectsShow fewer subjects
Medical researchOrgan and tissue donation and transplantationResearch administration and funding
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 24, 2017
Referred to the Subcommittee on Health.
Feb 17, 2017
Referred to the House Committee on Energy and Commerce.
Feb 17, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 24, 2017

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act or the Safe RESEARCH Act

This bill amends the Public Health Service Act to prohibit the use of tissue from an induced abortion in research conducted or supported by the National Institutes of Health (NIH). Research with human fetal tissue or alternatives to human fetal tissue (e.g., stem cells) conducted or supported by the NIH must meet requirements currently applied only to research on the transplantation of human fetal tissue for therapeutic purposes, including requirements for the informed consent of the donor and researcher. Research conducted or supported by the NIH may use human fetal tissue only if the tissue was obtained in accordance with state law regulating anatomical gifts.

Currently, executive branch officials may not prohibit the NIH from conducting or supporting research on the transplantation of human fetal tissue for therapeutic purposes. The bill repeals that limitation on executive branch officials.

The bill repeals a requirement that the NIH fund certain proposals for research on the transplantation of human fetal tissue for therapeutic purposes.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1203: Safe RESEARCH Act. 115th Congress. Open America. https://openamerica.io/bill/115-HR-1203/
MLA
"H.R. 1203: Safe RESEARCH Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-1203/.
Bluebook (legal)
H.R. 1203, 115th Cong. (2026), https://openamerica.io/bill/115-HR-1203/.
Markdown link
[H.R. 1203: Safe RESEARCH Act](https://openamerica.io/bill/115-HR-1203/)
Report a problem